KIR AND MHC CLASS I IMMUNOGENETICS IN SIV INFECTION
KIR AND MHC CLASS I IMMUNOGENETICS IN SIV INFECTION
批准号:
8357992
负责人:
David T Evans
金额:
$21.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-05-01 至 2012-04-30
关键词:
Animal ExperimentsDisease ProgressionFundingGeneticGenetic PolymorphismGrantHIV-1Histocompatibility Antigens Class IImmunogeneticsIndividualInfectionLigandsMHC Class I GenesMacaca mulattaNational Center for Research ResourcesNatural Killer CellsNew EnglandPlayPrimatesPrincipal InvestigatorRegulationResearchResearch InfrastructureResourcesRoleSIVSourceUnited States National Institutes of Healthbasecostdesignresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
Genetic evidence indicates that KIR and HLA class I polymorphisms play an important role in determining the rate of disease progression in HIV-1 infected individuals. However, the immunological mechanisms underlying these observations are poorly understood. We recently identified Mamu-A1*00201 (Mamu-A*02), a common MHC class I molecule in the rhesus macaque, as a ligand for Mamu-KIR3DL05. Using KIR- and MHC class I-defined animals, experiments can now be designed to examine the role of this KIR-MHC class I interaction in the regulation of NK cell responses to SIV infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluation of didehydro-Cortistatin A as a block-and-lock agent for a functional HIV cure in a macaque model
-
批准号:10403162
-
项目类别:
-
资助金额:$44.11万
-
财政年份:2021
-
负责人:David T Evans
-
依托单位:
Evaluation of didehydro-Cortistatin A as a block-and-lock agent for a functional HIV cure in a macaque model
-
批准号:10591883
-
项目类别:
-
资助金额:$45.09万
-
财政年份:2021
-
负责人:David T Evans
-
依托单位:
Tethering lentiviral restriction to Fc-mediated antibody responses
-
批准号:10425358
-
项目类别:
-
资助金额:$70.77万
-
财政年份:2020
-
负责人:David T Evans
-
依托单位:
Tethering lentiviral restriction to Fc-mediated antibody responses
-
批准号:10082732
-
项目类别:
-
资助金额:$45.44万
-
财政年份:2020
-
负责人:David T Evans
-
依托单位:
Tethering lentiviral restriction to Fc-mediated antibody responses
-
批准号:10203816
-
项目类别:
-
资助金额:$45.58万
-
财政年份:2020
-
负责人:David T Evans
-
依托单位:
Tethering lentiviral restriction to Fc-mediated antibody responses
-
批准号:10661036
-
项目类别:
-
资助金额:$77.6万
-
财政年份:2020
-
负责人:David T Evans
-
依托单位:
Assessing ADCC and Fc-mediated Protection against HIV
-
批准号:10671615
-
项目类别:
-
资助金额:$76.71万
-
财政年份:2019
-
负责人:David T Evans
-
依托单位:
Assessing ADCC and Fc-mediated Protection against HIV
-
批准号:10808458
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2019
-
负责人:David T Evans
-
依托单位:
Assessing ADCC and Fc-mediated Protection against HIV
-
批准号:10226317
-
项目类别:
-
资助金额:$76.5万
-
财政年份:2019
-
负责人:David T Evans
-
依托单位:
Assessing ADCC and Fc-mediated Protection against HIV
-
批准号:10458659
-
项目类别:
-
资助金额:$76.76万
-
财政年份:2019
-
负责人:David T Evans
-
依托单位:
Fcgamma receptor-mediated suppression of immunodeficiency virus replication
-
批准号:9275920
-
项目类别:
-
资助金额:$76.52万
-
财政年份:2015
-
负责人:David T Evans
-
依托单位:
Lentiviral Resistance to Tetherin
-
批准号:8790734
-
项目类别:
-
资助金额:$43.24万
-
财政年份:2012
-
负责人:David T Evans
-
依托单位:
Lentiviral Resistance to Tetherin
-
批准号:8415838
-
项目类别:
-
资助金额:$14.36万
-
财政年份:2012
-
负责人:David T Evans
-
依托单位:
Lentiviral Resistance to Tetherin
-
批准号:8604135
-
项目类别:
-
资助金额:$51.02万
-
财政年份:2012
-
负责人:David T Evans
-
依托单位:
Lentiviral Resistance to Tetherin
-
批准号:8326887
-
项目类别:
-
资助金额:$43.75万
-
财政年份:2012
-
负责人:David T Evans
-
依托单位:
Lentiviral Resistance to Tetherin
-
批准号:8894969
-
项目类别:
-
资助金额:$3.39万
-
财政年份:2012
-
负责人:David T Evans
-
依托单位:
Lentiviral Resistance to Tetherin
-
批准号:8717000
-
项目类别:
-
资助金额:$23.02万
-
财政年份:2012
-
负责人:David T Evans
-
依托单位:
A NOVEL ASSAY FOR ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY
-
批准号:8357976
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2011
-
负责人:David T Evans
-
依托单位:
KIR and MHC Class I Immunogenetics in SIV Infection
-
批准号:10054150
-
项目类别:
-
资助金额:$70.42万
-
财政年份:2011
-
负责人:David T Evans
-
依托单位:
KIR and MHC Class I Immunogenetics in SIV Infection
-
批准号:10295770
-
项目类别:
-
资助金额:$70.71万
-
财政年份:2011
-
负责人:David T Evans
-
依托单位:
海外基金